The Gen-Probe APTIMA Combo 2 assay has previously been reported to have a high sensitivity. The end point of this assay was evaluated using highly purified chlamydial elementary bodies (EBs). The performance of the APTIMA Combo 2 assay was compared with a commercially available PCR kit, AMPLICOR Chlamydia trachomatis. The number of inclusions of C. trachomatis at the end point of the APTIMA Combo 2 assay was 0.005 inclusion-forming units (i.f.u.) ml−1, which was equivalent to 0.008 EBs per assay. The end point of the AMPLICOR kit was 5 i.f.u. ml−1 (equivalent to 0.5 EB per assay). The efficacy of the AMPLICOR C. trachomatis assay was inhibited by phosphate or Fe2+ ion, while these had no effect on the APTIMA Combo 2 assay. In conclusion, the APTIMA Combo 2 assay appears to have a greater sensitivity than the AMPLICOR C. trachomatis assay for detection of C. trachomatis, while demonstrating few problems with inhibitory substances such as phosphate and Fe2+ ion.
BassC. A.,
JungkindD. L.,
SilvermanN. S.,
BondiJ. M.1993; Clinical evaluation of a new polymerase chain reaction assay for detection of Chlamydia trachomatis in endocervical specimens. J Clin Microbiol 31:2648–2653
BauwensJ. E.,
ClarkA. M.,
StammW. E.1993; Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay. J Clin Microbiol 31:3023–3027
BeattyW. L.,
MorrisonR. P.,
ByrneG. I.1994; Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 58:686–699
ChongS.,
JangD.,
SongX.,
MahonyJ.,
PetrichA.,
BarrigaP.,
CherneskyM.2003; Specimen processing and concentration of Chlamydia trachomatis added can influence false-negative rates in the LCx assay but not in the APTIMA Combo 2 assay when testing for inhibitors. J Clin Microbiol 41:778–782[CrossRef]
de BarbeyracB.,
RodriguezP.,
DutilhB.,
Le RouxP.,
BebearC.1995; Detection of Chlamydia trachomatis by ligase chain reaction compared with polymerase chain reaction and cell culture in urogenital specimens. Genitourin Med 71:382–386
GaydosC. A.,
QuinnT. C.,
WillisD.,
WeissfeldA.,
HookE. W.,
MartinD. H.,
FerreoD. V.,
SchachterJ.2003; Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol 41:304–309[CrossRef]
GoessensW. H. F.,
MoutonJ. W.,
van der MeijdenW. I.,
DeelenS.,
Rijsoort-VosT. H.,
Lemmens-den ToomN.,
VerbrughH. A.,
VerkooyenR. P.1997; Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine. J Clin Microbiol 35:2628–2633
HanadaH.,
Ikeda-DantsujiY.,
NaitoM.,
NagayamaA.2003; Infection of human fibroblast-like synovial cells with Chlamydia trachomatis results in persistent infection and interleukin-6 production. Microb Pathog 34:57–63[CrossRef]
JensenI. P.,
ThorsenP.,
MollerB. R.1997; Sensitivity of ligase chain reaction assay of urine from pregnant women for Chlamydia trachomatis
. Lancet 349:329–330
MahonyJ. B.,
ChongS.,
JangD.,
LuinstraK.,
FaughtM.,
DalbyD.,
SellorsJ.,
CherneskyM.1998; Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 36:3122–3126
MiyashitaN.,
MatsumotoA.1992; Establishment of a particle-counting method for purified elementary bodies of chlamydiae and evaluation of sensitivities of the IDEIA Chlamydia kit and DNA probe by using the purified elementary bodies. J Clin Microbiol 30:2911–2916
MiyashitaN.,
MatsumotoA.,
NikiY.,
MatsushimaT.1996; Evaluation of the sensitivity and specificity of a ligase chain reaction test kit for the detection of Chlamydia trachomatis
. J Clin Pathol 49:515–517[CrossRef]
NagayamaA.,
NakaoT.,
TaenH.1988; In vitro activities of ofloxacin and four other new quinolone-carboxylic acids against Chlamydia trachomatis
. Antimicrob Agents Chemother 32:1735–1737[CrossRef]
NotomiT.,
IkedaY.,
OkadomeA.,
NagayamaA.1998; The inhibitory effect of phosphate on the ligase chain reaction used for detecting Chlamydia trachomatis
. J Clin Pathol 51:306–308[CrossRef]
OkadomeA.,
NotomiT.,
NomuraS.,
NagayamaA.1999; Reactivity of a dual amplified chlamydia immunoassay with different serovars of Chlamydia trachomatis
. Int J STD AIDS 10:460–463[CrossRef]
PetersonE. M.,
DarrowV.,
BlandingJ.,
AarnaesS.,
de la MazaL. M.1997; Reproducibility problems with the AMPLICOR PCR Chlamydia trachomatis test. J Clin Microbiol 35:957–959
RahamanM. U.,
CheemaM. A.,
SchumacherH. R.,
HudsonA. P.1992; Molecular evidence for the presence of chlamydia in the synovium of patients with Reiter's syndrome. Arthritis Rheum 35:521–529[CrossRef]
VerkooyenR. P.,
LuijendijkA.,
HuismanW. M.,
GoessensW. H. F.,
KluytmansJ. A. J. W.,
van Rijsoort-VosJ. H.,
VerbrughH. A.1996; Detection of PCR inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay. J Clin Microbiol 34:3072–3074